Even with today's drop, MC is still over $400M
2 year low
To those that were previously wondering where the shorters closing liquidity would come from.... just look at the volume yesterday and todayAustralia's Lake Resources tanks to 2-year low on lithium carbonate output delay
Tuesday, 20th June 2023, 11:26:24 am
- Shares of Lake Resources (LKE) tank as much as 21.1% to A$0.300, hitting their lowest level since June 18, 2021
- Shares closed 20% lower on Monday after the lithium explorer announced a three-year delay to first production from its Kachi project in Argentina and more than doubled its cost estimate
- LKE tops losses in benchmark stock index
- About 30 mln shares change hands, vs the 30-day average volume of ~13.6 mln shares
- Stock down 52.5% this year, as of last close
- Forums
- ASX - By Stock
- Ann: Two Phase Development to Targeted Production of 50Ktpa
Even with today's drop, MC is still over $400M 2 year lowTo...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LKE (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $66.74M |
Open | High | Low | Value | Volume |
3.8¢ | 4.1¢ | 3.8¢ | $296.0K | 7.491M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 34999 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 348985 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34999 | 0.040 |
8 | 780204 | 0.039 |
29 | 2155654 | 0.038 |
20 | 2334622 | 0.037 |
24 | 1855029 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 328985 | 6 |
0.042 | 1084072 | 10 |
0.043 | 148131 | 3 |
0.044 | 1268111 | 10 |
0.045 | 1051087 | 7 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
LKE (ASX) Chart |